Nail Salon Workers Subject to Dangerous Chemicals
Dangerous Chemicals Injury Lawsuits. The ongoing exposure of chemicals used in nail salons may be associated with an array of serious adverse reactions that has sickened many cosmetic workers and, in some cases, their children and unborn children, according to a breaking report in The New York Times. Parker Waichman is concerned … [Read more...] about Nail Salon Workers Subject to Dangerous Chemicals
FDA Increases Oversight of Endoscopes Linked to ‘Superbug’ Infections
Endoscopes Associated With Infections. The Food and Drug Administration (FDA) is increasing oversight of endoscopes associated with a number of "superbug" infection outbreaks. The FDA has released stricter guidelines for manufacturers of reusable medical instruments, including specialized endoscopes – duodenoscopes – … [Read more...] about FDA Increases Oversight of Endoscopes Linked to ‘Superbug’ Infections
Imprelis Ban Raises Questions about EPA Oversight
Imprelis Ban Questions EPA Oversight. DuPont's Imprelis herbicide, blamed for causing damage and death to thousands of evergreen trees in Minnesota, Michigan, Indiana, Ohio, Pennsylvania, New Jersey and Wisconsin, was finally banned by the U.S. Environmental Protection Agency (EPA) last week. While the ban is good news, many are … [Read more...] about Imprelis Ban Raises Questions about EPA Oversight
GAO Sting Raises Questions About Medical Trial Oversight
GAO registered a fictitious institutional review board. A sting operation that allowed investigators to gain approval to test a fake medical device is raising serious questions about the oversight of medical trials. According to the Associated Press, as part of the sting, the Government Accountability Office (GAO) was also able to … [Read more...] about GAO Sting Raises Questions About Medical Trial Oversight
FDA Faulted Again for Oversight of Medical Devices
Safety Of Medical Device Scrutiny. Labs that develop medical devices haven't been receiving adequate scrutiny from the Food & Drug Administration (FDA), a new report says. According to the Project on Government Oversight (POGO), the FDA's Center for Devices and Radiological Health (CDRH) allows manufacturers and … [Read more...] about FDA Faulted Again for Oversight of Medical Devices
Vytorin Drug Scandal to Raise Questions about FDA Oversight
Vytorin Latest Drug Scandal. The Vytorin controversy has once again raised serious questions about the way the Food & Drug Administration (FDA) approves new drugs. At issue is the agency’s policy to allow drug clinical trials to measure only “proxy markers” and not the true outcome that the medication is supposed to … [Read more...] about Vytorin Drug Scandal to Raise Questions about FDA Oversight
